NuScale
SMR
$13.95
+8.22%
NuScale Power Corporation is a developer of small modular nuclear reactor (SMR) technology, operating within the Renewable Utilities industry with a focus on providing carbon-free, scalable, and safe nuclear power solutions. The company is a pioneering disruptor in the nuclear energy sector, aiming to commercialize its proprietary VOYGR power plants based on its innovative NuScale Power Module. The current investor narrative is dominated by significant financial and execution challenges, as highlighted by recent quarterly revenue misses and substantial cash burn, which have cast doubt on its commercialization timeline and financial sustainability amidst a wave of analyst price target cuts and key shareholder exits.…
SMR
NuScale
$13.95
Related headlines
SMR 12-Month Price Forecast
Wall Street consensus
Most Wall Street analysts maintain a constructive view on NuScale's 12-month outlook, with a consensus price target around $18.13 and implied upside of +30.0% versus the current price.
Average Target
$18.13
5 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
5
covering this stock
Price Range
$11 - $18
Analyst target range
Analyst coverage for NuScale is limited, with only 5 analysts providing estimates, and the available data shows institutional ratings but lacks a consensus price target, average target, or buy/hold/sell distribution, indicating insufficient analyst coverage to form a clear consensus. The implications of this limited coverage are significant: it typically denotes a small to mid-cap stock with high uncertainty and less efficient price discovery, which aligns with the stock's high beta of 2.25 and extreme volatility; the recent news of price target cuts and the lack of a published target range further underscore the high uncertainty and speculative nature of the investment thesis at this pre-commercial stage.
SMR Technical Analysis
The prevailing price trend for NuScale Power is a severe and sustained downtrend, with the stock down 61.58% over the past year and trading near the bottom of its 52-week range, currently at $12.67 versus a 52-week high of $57.42 and low of $8.85. This positioning, at approximately 10% of its 52-week range, suggests the stock is deeply distressed and may represent a potential value opportunity, albeit one with high risk of further fundamental deterioration. Recent momentum shows a modest short-term bounce with a 1-month price increase of 11.93%, which sharply contrasts with the 3-month decline of 1.40% and the severe 1-year loss; this divergence could signal a temporary oversold rebound, but the stock's beta of 2.25 indicates it is 125% more volatile than the broader market, making such moves prone to sharp reversals. Key technical support is at the 52-week low of $8.85, while resistance lies near the 52-week high of $57.42; a sustained break below the $8.85 support could trigger another leg down, while any recovery would face immense overhead supply, and the stock's extreme volatility, evidenced by a max drawdown of -82.86%, necessitates careful risk management for any potential position.
Beta
2.25
2.25x market volatility
Max Drawdown
-82.9%
Largest decline past year
52-Week Range
$9-$57
Price range past year
Annual Return
-56.4%
Cumulative gain past year
| Period | SMR Return | S&P 500 |
|---|---|---|
| 1m | +14.9% | +5.4% |
| 3m | +11.2% | +10.9% |
| 6m | -38.9% | +11.0% |
| 1y | -56.4% | +28.1% |
| ytd | -14.5% | +11.4% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
SMR Fundamental Analysis
Revenue growth is highly volatile and currently in severe decline, with Q4 2025 revenue of just $1.81 million representing a staggering 94.7% year-over-year contraction, and the multi-quarter trend shows revenue collapsing from $34.22 million in Q4 2024; this indicates the company's core business is generating minimal income as it remains in a pre-commercial, heavy R&D phase. The company is deeply unprofitable, with a Q4 2025 net loss of $50.83 million and a gross margin of -3.37%, reflecting negative gross profit; the operating margin of -40.22% and net margin of -28.11% show massive operating losses, and while the gross margin was positive in prior quarters (e.g., 52.35% in Q1 2025), the current quarter's negative figure highlights extreme revenue volatility and an inability to achieve scalable profitability. The balance sheet, while currently debt-free with a debt-to-equity ratio of 0, is being rapidly depleted by operational cash burn, as evidenced by a trailing-twelve-month free cash flow of -$460.12 million and an operating cash flow of -$203.70 million in the latest quarter; the current ratio of 4.30 shows ample short-term liquidity, but the negative ROE of -30.44% and ROA of -14.46% underscore severe inefficiency in capital usage as the company funds its development.
Quarterly Revenue
$1808000.0B
2025-12
Revenue YoY Growth
-0.94%
YoY Comparison
Gross Margin
-0.03%
Latest Quarter
Free Cash Flow
$-460117999.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is SMR Overvalued?
Given the company's consistent net losses and negative EBITDA, the primary valuation metric selected is the Price-to-Sales (P/S) ratio, as earnings-based multiples are not meaningful. The trailing P/S ratio is an extraordinarily high 73.70x, while the Enterprise Value-to-Sales ratio is an even more elevated 175.56x, reflecting a market capitalization of $5.17 billion against negligible revenue, which prices in speculative future sales growth that is far from certain. There is no direct industry average P/S provided in the data for a peer comparison; however, such extreme sales multiples are characteristic of pre-revenue, high-burn-rate development companies and suggest the market is assigning a significant premium based on the potential of its SMR technology rather than current fundamentals. Historically, the stock's own P/S ratio has been volatile but consistently high, ranging from 48.85x at the end of 2024 to 1,283.23x at the end of 2025, with the current 73.70x sitting below the most recent peak but still at a level that implies immense future commercial success is already priced in, leaving little margin for error or delay.
PE
-6.5x
Latest Quarter
vs. Historical
High-End
5-Year PE Range -75x~-3x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
-6.5x
Enterprise Value Multiple

